The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0124354
- By:
- Publication type:
- Article
Works matching AU Cen, Wen-Jian
Results: 5
1
2
The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
- Published in:
- American Surgeon, 2024, v. 90, n. 6, p. 1240, doi. 10.1177/00031348241227202
- By:
- Publication type:
- Article
3
A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy.
- Published in:
- American Surgeon, 2023, v. 89, n. 5, p. 1468, doi. 10.1177/00031348211063549
- By:
- Publication type:
- Article
4
City scale related to epidermal growth factor receptor mutations status in Chinese non-small cell lung cancer.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02558-4
- By:
- Publication type:
- Article
5
Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 19, p. 6610, doi. 10.1002/cam4.4197
- By:
- Publication type:
- Article